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Introduction
The major drawback of cancer therapy is the emer-
gence of multidrug-resistant (MDR) tumor cells,
which are cross-resistant to a broad range of struc-
turally and functionally unrelated agents, making it
difficult to treat these tumors. Therefore, one of the
most important points is to develop new strategies in
the treatment of multidrug-resistant carcinomas. Pho-
tosensitizers preferentially accumulate in the region
of a tumor and provide the possibility of killing MDR
cells or modulating the MDR phenotype [2]. PDT can
thus be promoted as an alternative treatment for
MDR tumors. In the last decade, investigations of
photodynamic effects in MDR cells in culture have
given promising results [4,5,12]. This relatively new
therapeutic modality for both neoplastic and non-
neoplastic diseases involves a dye (photosensitizer)
that has been selectively taken up by the target tissue,
the presence of molecular oxygen, and light activa-
tion. This combined treatment leads to the generation
of reactive oxygen species (ROS), such as singlet
molecular oxygen, hydroxyl radicals, and/or superox-
ide anions [18]. Cells are endowed with enzymatic
antioxidant defense systems to prevent cell death
caused by reactive oxygen species. One of the most
important antioxidant enzymes is superoxide dismu-
tase, which catalyzes the dismutation of O2
- to O2 and
H2O2 [9]. 
In this study, two human-origin colon adenocarci-
noma cell lines, LoVo (sensitive) and LoVo DX (dox-
orubicin-resistant), were treated with two photosensi-
tizers, Photofrin II and hypericin, and irradiated with
laser light. The intracellular accumulation of both
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photosensitizers and the influence of the photodynam-
ic therapy on cytosolic superoxide dismutase activity,
one of the crucial antioxidant enzymes, were exam-
ined. 
Materials and methods 
Cell lines. Two human colon adenocarcinoma cell lines were used
(doxorubicin-sensitive LoVo and doxorubicin-resistant LoVo DX).
The cell lines were purchased from Institute of Immunology and
Experimental Therapy, Polish Academy of Sciences. The cell lines
were grown in F-12 Ham medium nutrient mixture (Sigma) with
addition of 10% fetal bovine serum in 25 cm3 Falcon flasks. The
cells were maintained in a humidified atmosphere at 37°C and 5%
CO2. For the experiments the cells were removed by trypsinizing
and washed with phosphate-buffered saline. 
Photodynamic treatment. The cells were treated with 30 µg/ml
Photofrin II and 2.5 µg/ml hypericin in complete media for 4 h in
the dark. Then they were irradiated with a light dose of 2.5 J/cm2
using red laser light (λ= 632.8 nm). After irradiation, the cells were
incubated in a humidified atmosphere at 37°C and 5% CO2 for 30
min.
Photosensitizer distribution. Microcultures were derived from
the culture dishes and harvested on cover glasses for 24 hours.
The cells were subsequently incubated with two photosensitizers:
Photofrin II (Ph II) (QLT Phototherapeutics, Inc., Vancouver,
Canada), at a concentration of 30 µg/ml, and hypericin (Sigma), at
a concentration of 2.5 µg/ml, for 4 hours. After incubation, the
cells were fixed in 4% formalin buffer, washed in PBS, and exam-
ined under a fluorescence microscope (Nikon Eclipse TE 2000-E)
using a filter with an excitation wavelength of 528-553 nm and
emission wavelength of 578-633 nm. 
Immunofluorescence - P-gp expression. The cells were plated in
growth medium into 8-dip glass (Nunc) and grown for two days.
Then the cells were fixed in 4% formalin buffer and washed in
PBS. The intracellular localization of P-gp (1:40, Novoacstra) was
labeled with FITC (1:60, Sigma, excitation wavelength: 470 ± 20
nm and emission wavelength: λ=525 ± 20 nm). DAPI (0.2 µl/ml,
Molecular Probes, excitation wavelength: 541 nm and emission
wavelength: 445 ± 50 nm) was used for nuclei staining. Fluores-
cence was monitored using a microscope with LED illumination
(Zeiss Axio Imager.A1). 
SOD1 activity. After photodynamic treatment in vitro, the cells
were removed by trypsinizing and washed twice in PBS. Then the
cells were suspended in 50 mM phosphate buffer with a protease
inhibitor mixture (Complete Mini EDTA-free, Roche). SOD1
activity was measured using the method describe by Segura-
Aguilar [16]. The substrate for cytosolic superoxide dismutase is
provided by the reduction of oxygen during the autoxidation of
riboflavin in the presence of UV light. Hydrogen peroxide is quan-
titated using a coupled reaction where horseradish peroxidase cat-
alyzes the formation of a fluorescent product, 6,6'-diOH-(1,1'-
biphenyl)-3,3'-diacetic acid, from 4-OH-phenylacetic acid and
hydrogen peroxide. SOD1 activity was measured after incubation
with Ph II and Hyp without irradiation immediately following irra-
diation and 30 min after irradiation. 
Statistical analysis. The significance of the differences between
mean values of different groups of cells was assessed by Stu-
dent's t-test with values of p≤0.05 taken to imply statistical sig-
nificance.
Results 
Distribution of photosensitizers
The intracellular distribution of Ph II and Hyp in the
LoVo and LoVo DX cell lines was monitored after 4
hours of incubation with the photosensitizers. We
observed different distributions of these photosensitiz-
ers in the two investigated cell lines. The fluorescence
emitted by Photofrin II in LoVo was stronger than in
LoVo DX (Fig. 1C and D). In contrast, the accumula-
tion of Hyp was stronger in LoVo DX then in LoVo
cells (Fig. 1A and B). The present study shows that
both photosensitizers are diffused after 4 hours in the
cytoplasm predominantly in intracellular membranes
(Fig. 1A, B, C and D).
P-gp expression
The P-gp expression allowed evaluation of the level of
multidrug resistance in LoVo and LoVoDX cells (Fig.
2). In LoVo cells, P-glycoprotein is mainly accumulat-
ed in the cytoplasm and around the nuclear envelope
(Fig. 2A). Cytoplasmatic localization was also identi-
fied in LoVoDX cells, but we observed very intensive
fluorescence in the nuclear envelope (Fig. 2B).
SOD1 activity
SOD1 activity was seen to increase after incubation
with hypericin with and without irradiation compared
with all control cells without PDT (Fig. 3A). Howev-
er, in the cells treated with Ph II without irradiation,
the level of SOD1 activity was not significantly
decreased. An increase in enzyme activity was also
observed in the cells incubated with Ph II after irradi-
ation. (Fig. 3B). The activity was lower in both cell
lines treated with Ph II than in cells treated with hyper-
icin. SOD1 activity was observed to increase more in
LoVo cells treated hypericin compared with the LoVo
DX cell line. On the other hand, the level of SOD1
activity in the cells after Ph II PDT was not signifi-
cantly higher in LoVoDX cells compared with LoVo
cells. 
Discussion
The resistance to chemotherapeutic drugs is a frequent
phenomenon in which tumor cells develop cross-
resistance to chemically unrelated cytotoxic agents.
The overexpression of multidrug-resistant transporter
proteins in cell membranes is one of the reasons for the
resistance and can affect the efficacy of photodynamic
therapy by reducing the intracellular accumulation of
the photosensitizer [4,13].
The mechanism of cell response to PDT was inves-
tigated through the effects of two different photosensi-
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Fig. 1. Fluorescence distribution of (a) hypericin (cHyp=2.5 µg/ml) and (b) Photofrin II (cPhII=30 µg/ml) in LoVo and LoVoDX cell lines
after 4-h incubation; left: in LoVo, right: in LoVoDX cells. 
Fig. 2. LoVo (a) and LoVoDX (b) cells, right: DAPI fluorescence (blue) showing nuclear localization; left: P-glycoprotein labelled FITC
(green). 
tizing agents in cell lines sensitive to (LoVo) and
resistant to (LoVo DX) doxorubicin. Other investiga-
tions of MDR in PDT have focused primarily on P-gp-
mediated resistance, and differing results for specific
cells lines and photosensitizers have led to various
conclusions [14]. Cells overexpressing P-gp display a
reduced intracellular concentration of drugs that are
substrates for this transporter. In our previous studies,
some chemical features of the uptake of both photo-
sensitizers, Ph II and Hyp, were examined [3,10]. The
present study demonstrates the different sensitivities of
LoVo and LoVoDX cells to the two photosensitizers. 
Several authors have claimed that there was no dif-
ference in Photofrin II accumulation and photosensiti-
zation between sensitive and MDR Friend leukemia
cell lines. But the accumulation of the hematopor-
phyrin derivative was weaker in multicellular sphe-
roids derived from a human colorectal carcinoma cell
line, a kind of tumor that usually overexpresses P-gp
[2,11]. Doxorubicin-resistant and parental cancer cells
were treated with mTHPC (m-tetrahydroxyphenyl-
chlorin)-mediated PDT by Teiten et al. [17]. They
observed that the effect of photodynamic action was
significantly greater in the resistant than in the sensi-
tive, parental cell line. The highest applied concentra-
tion of 7.5 mM of mTHPC resulted in a significantly
greater accumulation in MDR cells. We observed the
same correlation for LoVoDX cells incubated with
hypericin compared with the LoVo cell line. Interest-
ingly, we obtained conflicting results after incubation
with Photofrin II. These differences in the accumula-
tion of the two photosensitizers in sensitive and resist-
ant colon cancer cells suggest that Ph II could be a
substrate for P-gp in MDR cells. However, Merlin et
al. [12] showed that the cellular accumulation of Ce6
in MCF-7 and MCF-7/DXR induced no significant
alteration after 3 h of incubation. These data were con-
sistent with the fact that Ce6 should not be a substrate
for P-glycoprotein. The authors demonstrated the
nuclear localization of P-gp in MCF-7/DX. We also
observed accumulation of P-gp in the nuclear environ-
ment and the cytoplasm, but in the sensitive cell line
LoVo (Fig. 2B). P-gp accumulated in the nuclei can be
involved in active cytotoxic drug removal [1,13]. In
turn, the LoVoDX cell line revealed intensive P-gp
accumulation in the cell membrane. 
Calcabrini et al. [1] demonstrated that earlier and
higher depolarization after treatment with BSAO and
spermine was found in the membrane of LoVoDX than
in the membrane of the drug-sensitive cells. In addi-
tion, basal ROS production was higher in LoVoDX
cells. Other results comparing Rh 123 (Rhodamine
123) and Photofrin® showed that there was lower
Photofrin® accumulation in resistant than in wild-type
cells. This seems to be mainly related to intracellular
drug turnover [4]. The results obtained in this study
suggest a more effective PDT action in the sensitive
human colon adenocarcinoma cell line.
Apart from the uptake of photosensitizer, this study
shows the antioxidant response to PDT. The present
experimental results suggest an influence of hypericin
and Photofrin II in combination with irradiation on
increased SOD1 activity caused by the generation of
ROS and oxidative stress in both cell lines. Johnson
and Pardini performed photodynamic treatment with
hypericin on EMT6 cells. A significant increase in
SOD activity was already noticed after 30 minutes [8].
Golab et al. [6] showed that Ph II-mediated PDT
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Fig. 3. The effect of hypericin (a) and Photofrin (b), and light on cytosolic superoxide dismutase activity (SOD1). The activity was meas-
ured control cells without PDT, after incubation with Ph II and Hyp without irradiation, directly after irradiation and after 30 min. p≤0.05
statistically significant compared with the control.
induced the expression of MnSOD in murine colon-26
(C-26). The inhibition of SOD activity in tumor cells
induced an increase in the cytotoxic effect of PDT. In
contrast, transient transfection with MnSOD gene
resulted in decreased effectiveness of PDT. These
results suggest that MnSOD plays a leading role in the
response to PDT and that mitochondria impairment
may be a critical factor in phototoxicity. The SODs
appear to be important antioxidative enzymes that reg-
ulate the sensitivity of cancer cells in some therapeutic
methods, such as photodynamic therapy [7]. 
This study indicates a difference in the uptake of
various photosensitizers by two colon adenocarcinoma
cell lines. We suggest that the stronger accumulation of
Ph II in LoVo and Hyp in LoVoDX cells causes the
impairment of SOD1 activity after PDT. On the other
hand, weaker fluorescence was observed in cells with
higher SOD1 activity after PDT. Verification of the
dependency between dyes applied in PDT and mul-
tidrug-resistant transporters could clarify the problem
of the proper photosensitizer. The development and
characterization of multidrug-resistant cells not only
helps to understand the mechanism of PDT in the
resistance of tumor cells, but also may contribute to
the application of more effective treatment. The search
for new antitumor drugs has been directed toward find-
ing compounds having a novel mechanism of action,
activity against resistant cancers, and a higher thera-
peutic index [2,4,15].
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